Radiopharmaceutical Market To Expand Lucratively With USD 11.9 Bn Earnings By 2028

According to study of Zion Market Research, Radiopharmaceutical industry accrued ROI of approximately around US$ 5.8 billion in 2021 and is expected to gain income of almost US$ 11.9 billion in 2028. Apparently, Radiopharmaceutical Market is set to register humungous gains of nearly 8.2% in time interval of 2022 to 2028. Moreover, expansion of radiopharmaceutical market over next six years is subject to humungous demand for nuclear drugs such as PET scans & SPECT scans for diagnosing ailments including cancer & other forms of chronic disorders during its preliminary phase. In addition to this, large-scale use of medical imaging techniques as a diagnostic method is enlarging scope of radiopharmaceutical industry surge. Furthermore, rise in diagnostic units in developed countries such as Canada, the U.S., Germany, and the UK will open new vistas of growth for radiopharmaceutical industry. Massive utility of 99m Tc radiopharmaceutical in neuroendocrine tumor imaging method as well as thyroid uptake pertechnetate will exalt industry landscape. Use of new technologies in nuclear imaging including PET and SPECT will enlarge market size. Nonetheless, massive costs incurred in producing radiopharmaceuticals in comparison to ROI can restrict growth of radiopharmaceutical industry.  

Technetium-99 To Lead Radioisotope Type Segment By 2028

Expansion of technetium-99 segment over next six years can be credited to use of the radioisotope for morphological imaging of internal body parts such as kidneys, liver, and bones. Apart from this, easy access of this radioisotope at reduced prices is set to produce huge demand for radioisotope in near future.

Oncology Segment To Expand Rapidly Over Forecasting Timeline

Swift elevation of oncology segment in next six years can be credited to rise in occurrence of cancer across various age-groups of population. In addition to this, rise in use of PET methods for diagnosing cancer will have huge impact on growth of oncology segment.

Hospitals Segment To Account Significantly Towards Overall Market Size By 2028

A prominent rise in segmental expansion over ensuing years can be due to acceptance of myriad imaging techniques involving MRI scan or PET scan coupled with rise in presence of medical experts in radiology department globally. Additionally, humungous use of radiopharmaceutical in hospitals and clinics has paved a way for segmental expansion.

North America To Make Notable Contributions Towards Regional Market Growth By 2028

Rise in occurrence of cancer and easy access to radiopharmaceuticals will contribute majorly towards regional market size. Prominent increase in use of nuclear medicine by doctors in countries such as Canada and the U.S. will account noticeably towards growth of radiopharmaceutical market in North America.

Some of the key players profiled in study and impacting market growth are The Bracco Group, Jubilant Pharmova, IBA Molecular Imaging Private Limited, Lantheus Holdings, Inc., Nordion Inc., Mallinckrodt Pharmaceuticals, Bayer AG, Cardinal Health, Inc., GE Healthcare, Advanced Accelerator Applications, Eczacibasi-Monrol Nuclear Products, and Siemens Healthineers AG.

Browse the full “Radiopharmaceutical Market - By Radioisotope Type (Technetium-99, Fluorine-18, Iodine-131, And Leutetium-177), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, And Nephrology), By Source (Cyclotrons And Nuclear Reactors), And By End-User (Hospitals And Diagnostic Labs): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends And Forecast, 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/radiopharmaceutical-market

The global Radiopharmaceutical Market is segmented as follows:

By Radioisotope Type

• Technetium-99
• Fluorine-18
• Iodine-131
• Leutetium-177

By Application

• Oncology
• Cardiology
• Gastroenterology
• Neuroendocrinology
• Neurology
•  Nephrology

By Source

• Cyclotrons
• Nuclear Reactors

By End-User

• Hospitals
• Diagnostic Labs

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com